X @Bloomberg

The blockbuster success of Ozempic and Wegovy made Novo seem unstoppable — but now the drugmaker faces a host of challengesOur Bloomberg reporters answer your questions: https://t.co/X96rPpBKVG https://t.co/sXZq9Akgyy ...